People living with serious illness or approaching end-of-life often experience anxiety and depression despite evidence-based counseling, medical interventions, and compassionate palliative care. Many medications to treat anxiety and depression cause notable side effects, take time to become effective, and may not alleviate the emotional suffering and anguish from serious illness or a terminal diagnosis.

 

This webinar explores the history of psychedelic drugs, research results and opportunities, available resources, and their potential to alleviate suffering and improve quality of life for those experiencing serious illness, such as cancer, or those approaching end-of-life.

 

Please note: While CaringMatters does not take an official position on the use of psychedelic drugs and specific psychedelic-assisted therapies, we are proud to provide a forum for discussion and education.

​

Presenter: Mark Bates, Clinical Psychologist, Sunstone Therapies

​

Mark Bates is a clinical psychologist at Sunstone Therapies who provides psychedelic-assisted therapy with a focus on whole person healing. Mark believes that psychedelic therapy helps people heal core wounds and access their higher selves in unique ways. Mark received his clinical psychology degree from the military's medical school and completed the Center for Psychedelic Therapies and Research certificate program at the California Institute of Integral Studies. He has also received training in multiple psychedelic-assisted psychotherapies and participated in ethnobotany studies in Ecuador and Brazil.